Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2021 Nov 27

PMID 34827579

Citations 24

Authors

Yu Ji

Hangil Lee

Shawn Kaura

James Yip

Hao Sun

Longfei Guan

Wei Han

Yuchuan Ding

Affiliations

Soon will be listed here.

Abstract

Obesity is a highly prevalent public health concern, attributed to multifactorial causes and limited in treatment options. Several comorbidities are closely associated with obesity such as the development of type 2 diabetes mellitus (T2DM), cardiovascular and cerebrovascular diseases, and nonalcoholic fatty liver disease (NAFLD). Bariatric surgery, which can be delivered in multiple forms, has been remarked as an effective treatment to decrease the prevalence of obesity and its associated comorbidities. The different types of bariatric surgery create a variety of new pathways for food to metabolize in the body and truncate the stomach's caliber. As a result, only a small quantity of food is tolerated, and the body mass index noticeably decreases. This review describes the improvements of obesity and its comorbidities following bariatric surgery and their mechanism of improvement. Additionally, endocrine function improvements after bariatric surgery, which contributes to the patients' health improvement, are described, including the role of glucagon-like peptide-1 (GLP-1), fibroblast growth factors 19 and 21 (FGF-19, FGF-21), and pancreatic peptide YY (PYY). Lastly, some of the complications of bariatric surgery, including osteoporosis, iron deficiency/anemia, and diarrhea, as well as their potential mechanisms, are described.

Citing Articles

Metabolic/bariatric surgery optimization: a position statement by Arabic association for the study of diabetes and metabolism (AASD).

Soliman A, Magd Eldin Saleem H, El Meligi A, Naguib M, Sobh Mohamed R, Abdelaziz G Diabetol Metab Syndr. 2025; 17(1):37.

PMID: 39881371 PMC: 11776182. DOI: 10.1186/s13098-024-01564-w.

Medial orbitofrontal cortex structure, function, and cognition associates with weight loss for laparoscopic sleeve gastrectomy.

Li X, Zhang W, Bi Y, Duan Y, Sun X, Chen J Obesity (Silver Spring). 2025; 33(2):308-320.

PMID: 39873400 PMC: 11774012. DOI: 10.1002/oby.24207.

The Triad of Risk: Linking MASLD, Cardiovascular Disease and Type 2 Diabetes; From Pathophysiology to Treatment.

Michalopoulou E, Thymis J, Lampsas S, Pavlidis G, Katogiannis K, Vlachomitros D J Clin Med. 2025; 14(2).

PMID: 39860434 PMC: 11765821. DOI: 10.3390/jcm14020428.

Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome-An Update.

Elfaki I, Mir R, Elnageeb M, Hamadi A, Alharbi Z, Bedaiwi R Medicina (Kaunas). 2025; 61(1).

PMID: 39859066 PMC: 11767019. DOI: 10.3390/medicina61010083.

Bariatric surgery for treatment of morbid obesity in adults.

Park K, Jun K Korean J Intern Med. 2025; 40(1):24-39.

PMID: 39778524 PMC: 11725483. DOI: 10.3904/kjim.2024.219.

References

Bedogni G, Miglioli L, Masutti F, Castiglione A, Croce L, Tiribelli C . Incidence and natural course of fatty liver in the general population: the Dionysos study. Hepatology. 2007; 46(5):1387-91. DOI: 10.1002/hep.21827. View

Yang J, Gao Z, Williams D, Wang C, Lee S, Zhou X . Effect of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy on fasting gastrointestinal and pancreatic peptide hormones: A prospective nonrandomized trial. Surg Obes Relat Dis. 2018; 14(10):1521-1529. DOI: 10.1016/j.soard.2018.06.003. View

Melmer A, Sturm W, Kuhnert B, Engl-Prosch J, Ress C, Tschoner A . Incidence of Gallstone Formation and Cholecystectomy 10 Years After Bariatric Surgery. Obes Surg. 2015; 25(7):1171-6. DOI: 10.1007/s11695-014-1529-y. View

Tangalakis L, Tabone L, Spagnoli A, Muehlbauer M, Omotosho P, Torquati A . Effects of Roux-en-Y Gastric Bypass on Osteoclast Activity and Bone Density in Morbidly Obese Patients with Type 2 Diabetes. Obes Surg. 2019; 30(1):290-295. PMC: 7515205. DOI: 10.1007/s11695-019-04154-2. View

Kirk E, Reeds D, Finck B, Mayurranjan S, Mayurranjan M, Patterson B . Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology. 2009; 136(5):1552-60. PMC: 2677125. DOI: 10.1053/j.gastro.2009.01.048. View

English W, Williams D . Metabolic and Bariatric Surgery: An Effective Treatment Option for Obesity and Cardiovascular Disease. Prog Cardiovasc Dis. 2018; 61(2):253-269. DOI: 10.1016/j.pcad.2018.06.003. View

Nett P, Borbely Y, Kroll D . Micronutrient Supplementation after Biliopancreatic Diversion with Duodenal Switch in the Long Term. Obes Surg. 2016; 26(10):2469-74. DOI: 10.1007/s11695-016-2132-1. View

Bretault M, Laroche S, Lacorte J, Barsamian C, Polak M, Raffin-Sanson M . Postprandial GLP-1 Secretion After Bariatric Surgery in Three Cases of Severe Obesity Related to Craniopharyngiomas. Obes Surg. 2016; 26(5):1133-7. DOI: 10.1007/s11695-015-1977-z. View

Damms-Machado A, Mitra S, Schollenberger A, Kramer K, Meile T, Konigsrainer A . Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int. 2015; 2015:806248. PMC: 4330959. DOI: 10.1155/2015/806248. View

10.

Moreno-Arciniegas A, Falckenheiner-Soria J, Bancalero-de Los Reyes J, Camacho-Ramirez A, Mayo-Ossorio M, Pacheco-Garcia J . The main participation of the enterohormone GLP-1 after bariatric surgery. Minerva Chir. 2018; 74(1):7-13. DOI: 10.23736/S0026-4733.18.07681-2. View

11.

Moretto M, Kupski C, da Silva V, Padoin A, Mottin C . Effect of bariatric surgery on liver fibrosis. Obes Surg. 2011; 22(7):1044-9. DOI: 10.1007/s11695-011-0559-y. View

12.

Guerrero-Perez F, Casajoana A, Gomez-Vaquero C, Virgili N, Lopez-Urdiales R, Hernandez-Montoliu L . Changes in Bone Mineral Density in Patients with Type 2 Diabetes After Different Bariatric Surgery Procedures and the Role of Gastrointestinal Hormones. Obes Surg. 2019; 30(1):180-188. DOI: 10.1007/s11695-019-04127-5. View

13.

Diemieszczyk I, Wozniewska P, Golaszewski P, Drygalski K, Nadolny K, Ladny J . Does weight loss after laparoscopic sleeve gastrectomy contribute to reduction in blood pressure?. Pol Arch Intern Med. 2021; 131(7-8):693-700. DOI: 10.20452/pamw.16023. View

14.

Buchwald H, Buchwald J . Metabolic (Bariatric and Nonbariatric) Surgery for Type 2 Diabetes: A Personal Perspective Review. Diabetes Care. 2019; 42(2):331-340. DOI: 10.2337/dc17-2654. View

15.

Nemati R, Lu J, Dokpuang D, Booth M, Plank L, Murphy R . Increased Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Correlate with Improvement in Type 2 Diabetes in a Randomized Trial. Obes Surg. 2018; 28(9):2672-2686. DOI: 10.1007/s11695-018-3216-x. View

16.

Smith E, Polanco G, Yaqub A, Salehi M . Altered glucose metabolism after bariatric surgery: What's GLP-1 got to do with it?. Metabolism. 2017; 83:159-166. DOI: 10.1016/j.metabol.2017.10.014. View

17.

Armstrong M, Hull D, Guo K, Barton D, Hazlehurst J, Gathercole L . Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis. J Hepatol. 2015; 64(2):399-408. PMC: 4713865. DOI: 10.1016/j.jhep.2015.08.038. View

18.

Magouliotis D, Tasiopoulou V, Sioka E, Chatedaki C, Zacharoulis D . Impact of Bariatric Surgery on Metabolic and Gut Microbiota Profile: a Systematic Review and Meta-analysis. Obes Surg. 2017; 27(5):1345-1357. DOI: 10.1007/s11695-017-2595-8. View

19.

Guida C, Stephen S, Watson M, Dempster N, Larraufie P, Marjot T . PYY plays a key role in the resolution of diabetes following bariatric surgery in humans. EBioMedicine. 2019; 40:67-76. PMC: 6413583. DOI: 10.1016/j.ebiom.2018.12.040. View

20.

Aminian A, Aleassa E, Bhatt D, Tu C, Khorgami Z, Schauer P . Bariatric surgery is associated with a lower rate of death after myocardial infarction and stroke: A nationwide study. Diabetes Obes Metab. 2019; 21(9):2058-2067. DOI: 10.1111/dom.13765. View